Trials / Completed
CompletedNCT03039075
Metformin SR Tablet (DuLeNing) and Glucophage in Patients With Type 2 Diabetes
Comparison of Metformin Hydrochloride Sustained-release Tablet (DuLeNing) and Glucophage in Patients With Type 2 Diabetes
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 240 (actual)
- Sponsor
- Chongqing Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Metformin hydrochloride sustained-release tablets made in Conquer pharmaceutical co., LTD is approved by China Food And Drug Administration (cFDA). Whether its efficacy and safety are equal to Glucophage is unclear.
Detailed description
To perform a RCT for the comparison between Metformin hydrochloride sustained-release tablets made in Conquer pharmaceutical co., LTD and Glucophage .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metformin SR Tablet | Metformin SR Tablet made in Conquer pharmaceutical co., LTD |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2018-10-01
- Completion
- 2018-11-01
- First posted
- 2017-02-01
- Last updated
- 2019-07-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03039075. Inclusion in this directory is not an endorsement.